GlassScriptPhysician profile
Keva Garg
NPI 1447782131
$34,762.68
in general payments reported to CMS, 2019-2025
14 companies · $9,794 in 2025
The $9,794 reported for 2025 was more than what 80% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $104 · 2024: $25K · 2025: $9,794.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $25K · Food and Beverage: $5,057 · Travel and Lodging: $4,062 · Education: $362.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $25,282.56 |
| Food and Beverage | $5,056.50 |
| Travel and Lodging | $4,062.10 |
| Education | $361.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $24,519.34 | 2024-2025 | Micra, Evera Mri Xt Dr Surescan, Cobalt Dr Mri Surescan |
| Boston Scientific Corporation | $5,839.82 | 2024-2025 | General - Therapies, Sq-Rx Pulse Generator, Emblem Mri S-Icd |
| Biosense Webster, INC. | $2,130.61 | 2024-2025 | Carto 3, Qdot Micro Catheter, Octaray Mapping Catheter |
| Abbott Laboratories | $1,949.15 | 2025 | Aveir, Na, Ensite |
| Cardiva Medical, INC. | $103.77 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Ethicon US, LLC | $41.61 | 2024 | Dermabond Prineo, Stratafix, Surgicel Nu-Knit |
| Terumo Medical Corporation | $34.89 | 2024-2025 | Glidewire, Metacross Otw, Angio-Seal |
| Novo Nordisk INC | $30.37 | 2024 | Wegovy |
| Biotronik INC. | $26.50 | 2025 | |
| Chiesi USA, INC. | $25.90 | 2025 | Kengreal |
| Janssen Pharmaceuticals, INC | $21.77 | 2024 | Xarelto |
| Scpharmaceuticals INC. | $18.43 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.24 | 2025 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $2.28 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keva Garg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.